Principal investigator Daniel Feig, MD, PhD, of University of Alabama-Birmingham has successfully enrolled the first participant into the PTN study of lisinopril use for the control of high blood pressure in kids with kidney transplants.

Seven sites are currently recruiting participants into this study: Arkansas Children’s Hospital in Little Rock, Cincinnati Children’s Hospital, Children’s Mercy Hospital in Kansas City, Emory University & Children’s Healthcare of Atlanta, New York University Langone Medical Center, University of Alabama-Birmingham, and University of Michigan at Ann Arbor.

Results from the lisinopril study are expected by summer 2013.